References
- Bockman J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 1983; 15: 10–17
- Jeyarajaah A., Oram D., Jacobs I. Molecular events in endometrial carcinogenesis. Int. Gynecol. Cancer 1996; 6: 425–438, [CROSSREF]
- Sherman M. E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Path. 2000; 13: 295–308, [CSA], [CROSSREF]
- Gurin Ch. C., Federici M. G., Kang L., Boyd J. Causes and consequences of microcatellite in endometrial carcinoma. Cancer Res. 1999; 5: 9462–9466
- Risinger J. I., Hayes A. K., Maxwell G. L., Corney R. K., Dodge J. C., Barret A., Berchuck A. PTEN mutations in endometrial cancer is associated with favourable clinical and pathologic characteristics. Clin. Cancer Res. 1998; 4: 3005–3010, [PUBMED], [INFOTRIEVE], [CSA]
- Ikeda T., Yoshinag S., Semba S., Kondo E., Ohmari H., Horii A. Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial and serous carcinoma. Cancer 2000; 88: 814–824
- Lax S. F., Kendal B., Taschiro H., Slebas R. J., Ellenson L. H. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometroid and serous carcinomas. Nat. Genet. 1997; 17: 143–144, [CROSSREF]
- Ehrlich C. E., Young P. C.M., Stehman F. B., Sutton G. P., Alford W. M. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am. J. Obstet. Gynecol. 1988; 158: 796–807, [PUBMED], [INFOTRIEVE]
- Utsunomiya H., Suzuki T., Harada N., Ito K., Matsuzaki S., Konno R., Sato S., Yajima A., Susano H. Analysis of estrogen receptor alpha and beta in endometrial adenocarcinomas: correlation with ERbeta and clinicopathologic findings in 45 cases. Int. J. Gynecol. Pathol. 2000; 19(4)335–341, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gustafsson J.-A. Estrogen receptor β—a new dimension in estrogen mechanism of action. J. Endocrinol. 1999; 163: 379–383, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mc Inerney E. M., Weis K. E., Sun J., Mosselman S., Katzenellenbogen B. S. Transcription activation by the human estrogen receptor subtype β (ERβ) studies with ERβ and ERα receptor chimeras. Endocrinology 1998; 139(11)4513–4522, [CSA], [CROSSREF]
- Lubahn D. B., Moyer J. S., Golding T. S., Cause J. F., Korach K. S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 1993; 90(23)11162–11166, [PUBMED], [INFOTRIEVE], [CSA]
- Couse J. F., Lindzey J., Grandien K., Gustafsson J.-C., Korach K. S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha knockout mouse. Endocrinology 1997; 138(11)4613–4621, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Speroff L. A clinical understanding of the estrogen receptor. Ann. N.Y. Acad. Sci. 2000; 900: 26–39, [PUBMED], [INFOTRIEVE], [CSA]
- Paige L. A., Christensen D. J., Gron H., Norris J. D., Gottlin E. B., Padilla K. M., Chang C.-Y., Ballas L. M., Hamilton P. T., McDonnell D. P., Fowlkes DM. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha andERbeta. Proc. Acad. Sci. U.S.A. 1999; 96(7)399–4004
- Katzenellenbogen B. S., Korach K. S. Editional: a new actor in the estrogen receptor drama-enter ERβ. Endocrinology 1997; 138: 861–862, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Enmark E., Gustafsson J. A. Estrogen receptor β—a novel receptor opens up new possibilities for cancer diagnosis and treatment, endocrine related. Cancer 1998; 5: 213–222
- Cowley S. M., Hoare S., Mosselman S., Parker M. G. Estrogen receptors alfa and beta form heterodimers on DNA. J. Biol. Chem. 1997; 272(32)19858–19862, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jarvinen T. A.H., Pelto-Huikko M., Holli K., Isola J. Estrogen receceptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am. J. Pathol. 2000; 156: 29–35, [PUBMED], [INFOTRIEVE]
- Weihua Z., Saji S., Makinen S., Cheng G., Jensen E. V., Warner M., Gustafsson J.-A. Estrogen receptor (ER) beta a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. U.S.A. 2000; 97(11)5936–5941, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gotteland M., Desauty G., Delarue J. C., Liu L., May E. Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol. Cell. Endocrinol. 1995; 112(1)1–13, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moore J. T., McKeed D., Slent-Kesler K., Moore L., Jones S., Horn E., Su J., Kliewer S., Lehmann J., Willson T. Cloning and characterization of human estrogen receptor beta isoforms. Biochem. Biophys. Res. Commun. 1998; 247: 75–78, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pedersen S. B., Bruun J. M., Hube F., Kristensen K., Hauner H., Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influence of adipose cell differentiation and fat depot localization. Mol. Cell. Endocrinol. 2001; 27–37, [CROSSREF]
- Inoue S., Ogawa S., Horie K., Hoshino S., Goto W., Hosoi T., Tsutsumi O., Muramatsu M., Ouchi Y. An estrogen receptor beta isoforms that lacks exon 5 has dominant negative activity on both ERalfa and ERbeta. Biochem. Biophys. Res. Commun. 2000; 279: 814–819, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ogawa S., Inoue S., Orimo A., Hosoi T., Ouchi Y., Muramatsu S. FEBS Lett. 1998; 423(2)129–132, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bolling A., Miksicek R. J. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 2000; 14: 634–649, [CSA], [CROSSREF]
- Pike A. C.W., Brzozowski A. M., Hubbard R. E., Bonn T., Thorsell A.-G., Engstroom O., Ljunggren J., Gustafsson J.-A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and full antagonist. EMBO J. 1999; 18: 4608–4618, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Horvath G., Leser G., Hahlin M., Henriksson M. Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperplasia and adenocarcinoma. Int. J. Gynecol. Cancer 2000; 10: 128–136, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lemieux P., Fuqua S. The role of the estrogen receptor in tumor progression. J. Steroid Biochem. Mol. Biol. 1996; 56: 87–91, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shupnik M. A., Pitt L. K., Soh A. Y., Anderson A., Lopes M. B., Laws E. R. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J. Clin. Edocrinol. Metab. 1998; 83: 3965–3972, [CSA], [CROSSREF]
- Hall J. M., McDonnell D. P. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and it's a key regulator of the cellular response to estrogen and antiestrogens. Endocrinology 1999; 140: 5566–5578, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sivridis E., Giatromanolaki A., Koukourakis M., Anastasidis P. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch. 2001; 438: 470–477, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Navari J. R., Roland P. Y., Keh P., Salvesen H. B., Akslen L. A., Iversen O. E., Das S., Kothari R., Howey S., Philips B. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of 5′ end of the ER gene. Clin. Cancer Res. 2000; 6: 4026–4032, [PUBMED], [INFOTRIEVE], [CSA]
- Sivridis E., Giatromanolaki A. Prognostic aspects on endometrial hyperplasia and neoplasia. Virchows Arch. 2001; 439: 118–126, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Poola J., Abraham J., Baldwin K. Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA in distinct from that of estrogen receptor alpha. FEBS Lett. 2002; 516: 133–138, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Latil A., Bieche J., Vidaud D., Lidereau R., Berthon P., Cussenot O., Vidaud M. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Endocrinology 2001; 61: 1919–1926
- Omoto Y., Kobayashi S., Inoue S., Ogawa S., Toyama T., Yamashita H., Muramatsu M., Gustafsson J. A., Iwase H. Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur. J. Cancer 2002; 38: 380–386, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lazennec G., Bresson D., Lucas A., Chauveau C., Vignon F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001; 142(9)4120–4130, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brandenberger A., Tee M. K., Jaffe R. B. Estrogen receptor alfa (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-β in neoplastic tissue. J. Clin. Endocrinol. Metab. 1998; 83(3)1025–1028, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Iwao K., Miyoshi Y., Egawa Ch., Ikeda N., Noguchi S. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancer. Int. J. Cancer 2000; 88: 733–738, [PUBMED], [INFOTRIEVE]